Common Use | TAT-HA2 Fusion Peptide is a peptide-based delivery agent that combines the pH-sensitive HA2 fusion peptide from Influenza and the cell-penetrating peptide TAT from HIV. TAT-HA2 Fusion Peptide induces the cellular uptake of macromolecules into endosomes via the TAT moiety and to respond to the acidifying lumen of endosomes to cause membrane leakage and release of macromolecules into cells via the HA2 moiety |
Structure | |
Molecular Weight | 3432.92 |
Purity | ≥99% |
Molecular Formula | C149H243N53O39S |
CAS No. | 923954-79-4 |
Appearance | Solid |
Storage | Powder: -80 °C, 2 years; -20 °C, 1 year. In solvent: -80 °C, 6 months; -20 °C, 1 month (sealed storage, away from moisture and light, under nitrogen) |
Solubility | Soluble in water |
Catalog: CDCCP23-001L
Catalog: CDCCP23-002L
Catalog: CDCCP23-003L
Catalog: CDCCP23-004L
Catalog: CDCCP23-005L
Catalog: CDCCP23-007L
Catalog: CDCCP23-008L
Catalog: CDCCP23-009L